Pharmaceutical firm Jubilant Life Sciences today said it has repayed nearly Rs 900 crore ($202 million) for redemption of outstanding overseas bonds.
The company has made "Repayment of $202 million on account of outstanding foreign currency convertible bonds (FCCBs) including yield to maturity of $60 million," Jubilant Life Sciences said in a filing to the Bombay Stock Exchange (BSE).
"After the repayment of our last FCCBs amounting to $202 million, there are no major debt repayments due for the next 3 years," Jubilant Life Sciences chairman & Managing Director Shyam Bhartia said.
The company has repaid all the outstanding FCCBs on time in line with terms and conditions of the FCCB instruments, Jubilnat Life added.
Shares of Jubilant Life Sciences were today trading at Rs 166.55 in the afternoon trade on BSE, down 0.77% from its previous close.
